company background image
REG1

Revenio Group OyjHLSE:REG1V Stock Report

Market Cap

€1.5b

7D

-4.1%

1Y

53.2%

Updated

23 Sep, 2021

Data

Company Financials +
REG1V fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance5/6
Financial Health5/6
Dividends0/6

REG1V Overview

Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration in Finland, Italy, rest of Europe, the United States, and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Revenio Group Oyj
Historical stock prices
Current Share Price€58.15
52 Week High€33.50
52 Week Low€72.00
Beta1.41
1 Month Change-6.44%
3 Month Change-5.06%
1 Year Change53.23%
3 Year Change272.76%
5 Year Change520.82%
Change since IPO2,960.60%

Recent News & Updates

Sep 12
Is Revenio Group Oyj (HEL:REG1V) A Risky Investment?

Is Revenio Group Oyj (HEL:REG1V) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Aug 30
The Returns On Capital At Revenio Group Oyj (HEL:REG1V) Don't Inspire Confidence

The Returns On Capital At Revenio Group Oyj (HEL:REG1V) Don't Inspire Confidence

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

Jul 13
If You Like EPS Growth Then Check Out Revenio Group Oyj (HEL:REG1V) Before It's Too Late

If You Like EPS Growth Then Check Out Revenio Group Oyj (HEL:REG1V) Before It's Too Late

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

Jun 07
Is Revenio Group Oyj (HEL:REG1V) A Risky Investment?

Is Revenio Group Oyj (HEL:REG1V) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Shareholder Returns

REG1VFI Medical EquipmentFI Market
7D-4.1%0.9%1.4%
1Y53.2%44.7%26.3%

Return vs Industry: REG1V exceeded the Finnish Medical Equipment industry which returned 41.1% over the past year.

Return vs Market: REG1V exceeded the Finnish Market which returned 24.4% over the past year.

Price Volatility

Is REG1V's price volatile compared to industry and market?
REG1V volatility
REG1V Beta1.41
Industry Beta0.59
Market Beta1

Stable Share Price: REG1V is not significantly more volatile than the rest of Finnish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: REG1V's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a167Jouni Toijalahttps://www.reveniogroup.fi

Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration in Finland, Italy, rest of Europe, the United States, and internationally. The company offers ic100 and ic200 tonometers; Icare HOME, a device for self-measurement of eye pressure; Icare TONOVET Plus tonometers for animals; fundus imaging devices comprising EIDON, DRS, and DRSplus; MAIA, a microperimeter to measure the effectiveness of drugs for retinal disease treatment; COMPASS, which provides fundus perimetry with true-color confocal retinal images; and Ventica, to examine the variability in tidal breathing in children. It is also developing Cutica, a hyperspectral camera for dermatologists to detect skin cancers.

Revenio Group Oyj Fundamentals Summary

How do Revenio Group Oyj's earnings and revenue compare to its market cap?
REG1V fundamental statistics
Market Cap€1.54b
Earnings (TTM)€16.06m
Revenue (TTM)€71.31m

96.2x

P/E Ratio

21.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
REG1V income statement (TTM)
Revenue€71.31m
Cost of Revenue€21.03m
Gross Profit€50.28m
Expenses€34.22m
Earnings€16.06m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Oct 21, 2021

Earnings per share (EPS)0.60
Gross Margin70.51%
Net Profit Margin22.52%
Debt/Equity Ratio38.5%

How did REG1V perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

53%

Payout Ratio

Valuation

Is Revenio Group Oyj undervalued compared to its fair value and its price relative to the market?

7.6%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: REG1V (€58.15) is trading below our estimate of fair value (€62.91)

Significantly Below Fair Value: REG1V is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: REG1V is poor value based on its PE Ratio (96.2x) compared to the European Medical Equipment industry average (39.4x).

PE vs Market: REG1V is poor value based on its PE Ratio (96.2x) compared to the Finnish market (23.5x).


Price to Earnings Growth Ratio

PEG Ratio: REG1V is poor value based on its PEG Ratio (4.3x)


Price to Book Ratio

PB vs Industry: REG1V is overvalued based on its PB Ratio (22.9x) compared to the XE Medical Equipment industry average (4.9x).


Future Growth

How is Revenio Group Oyj forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

22.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: REG1V's forecast earnings growth (22.2% per year) is above the savings rate (0.2%).

Earnings vs Market: REG1V's earnings (22.2% per year) are forecast to grow faster than the Finnish market (7.2% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: REG1V's revenue (15.9% per year) is forecast to grow faster than the Finnish market (3.7% per year).

High Growth Revenue: REG1V's revenue (15.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: REG1V's Return on Equity is forecast to be high in 3 years time (25.8%)


Past Performance

How has Revenio Group Oyj performed over the past 5 years?

20.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: REG1V has high quality earnings.

Growing Profit Margin: REG1V's current net profit margins (22.5%) are higher than last year (20.5%).


Past Earnings Growth Analysis

Earnings Trend: REG1V's earnings have grown significantly by 20.8% per year over the past 5 years.

Accelerating Growth: REG1V's earnings growth over the past year (42.9%) exceeds its 5-year average (20.8% per year).

Earnings vs Industry: REG1V earnings growth over the past year (42.9%) underperformed the Medical Equipment industry 59.7%.


Return on Equity

High ROE: REG1V's Return on Equity (23.8%) is considered high.


Financial Health

How is Revenio Group Oyj's financial position?


Financial Position Analysis

Short Term Liabilities: REG1V's short term assets (€27.7M) exceed its short term liabilities (€14.9M).

Long Term Liabilities: REG1V's short term assets (€27.7M) exceed its long term liabilities (€26.7M).


Debt to Equity History and Analysis

Debt Level: REG1V's debt to equity ratio (38.5%) is considered satisfactory.

Reducing Debt: REG1V's debt to equity ratio has increased from 5.6% to 38.5% over the past 5 years.

Debt Coverage: REG1V's debt is well covered by operating cash flow (66.7%).

Interest Coverage: REG1V's interest payments on its debt are well covered by EBIT (157.8x coverage).


Balance Sheet


Dividend

What is Revenio Group Oyj current dividend yield, its reliability and sustainability?

0.55%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: REG1V's dividend (0.55%) isn’t notable compared to the bottom 25% of dividend payers in the Finnish market (1.68%).

High Dividend: REG1V's dividend (0.55%) is low compared to the top 25% of dividend payers in the Finnish market (3.64%).


Stability and Growth of Payments

Stable Dividend: REG1V is not paying a notable dividend for the Finnish market, therefore no need to check if payments are stable.

Growing Dividend: REG1V is not paying a notable dividend for the Finnish market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: REG1V is not paying a notable dividend for the Finnish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of REG1V's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.8yrs

Average management tenure


CEO

Jouni Toijala (53 yo)

1.33yrs

Tenure

€213,036

Compensation

Mr. Jouni Toijala serves as Chief Executive Officer of Revenio Group Oyj. He served as Chief Executive Officer of Innokas Medical Oy. He served as Managing Director of EMEA at Symbio, Inc. Mr. Toijala join...


CEO Compensation Analysis

Compensation vs Market: Jouni's total compensation ($USD250.01K) is below average for companies of similar size in the Finnish market ($USD853.06K).

Compensation vs Earnings: Insufficient data to compare Jouni's compensation with company performance.


Leadership Team

Experienced Management: REG1V's management team is considered experienced (3.8 years average tenure).


Board Members

Experienced Board: REG1V's board of directors are considered experienced (5.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Revenio Group Oyj's employee growth, exchange listings and data sources


Key Information

  • Name: Revenio Group Oyj
  • Ticker: REG1V
  • Exchange: HLSE
  • Founded: NaN
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €1.545b
  • Shares outstanding: 26.56m
  • Website: https://www.reveniogroup.fi

Number of Employees


Location

  • Revenio Group Oyj
  • Aeyritie 22
  • Vantaa
  • Uusimaa
  • 1510
  • Finland

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/23 21:38
End of Day Share Price2021/09/23 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.